Report Detail
Global Head Lice Infestation Drug Market Insights, Forecast to 2025
- RnM2931142 |
- 12 February, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person.
The Global Main Head Lice Infestation Drug Manufacturers are Bayer, Omega Pharma, Thornton and Ross, Prestige Brands and other manufacturers. Bayer is one of the largest manufacturers in the global Head Lice Infestation Drug market with 11.35% market share in 2015, followed by Omega Pharma with 7.98% market share.
The Head Lice Infestation Drug sales regions are mainly North America and Europe. North America is the largest region to consumption Head Lice Infestation Drug, whose consumption occupied about 31.40% in 2015, followed by Europe with 29.01% consumption share.
After a long investigation and research, we think people are very concerned about the Head Lice Infestation Drug content in the daily commodities. We recommend that some manufacturers would add Head Lice Infestation Drug to satisfy the market demanding for all household members and other close to head lice contacts should be checked.
The global Head Lice Infestation Drug market is valued at 340 million US$ in 2018 and will reach 450 million US$ by the end of 2025, growing at a CAGR of 3.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Head Lice Infestation Drug market based on company, product type, end user and key regions.
This report studies the global market size of Head Lice Infestation Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Head Lice Infestation Drug in these regions.
This research report categorizes the global Head Lice Infestation Drug market by top players/brands, region, type and end user. This report also studies the global Head Lice Infestation Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Market size by Product
Lotion
Creams
Shampoo
Other
Market size by End User
Children
Adult
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Head Lice Infestation Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Head Lice Infestation Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Head Lice Infestation Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Head Lice Infestation Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Head Lice Infestation Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Head Lice Infestation Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Head Lice Infestation Drug Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Head Lice Infestation Drug Market Size Growth Rate by Product
- 1.4.2 Lotion
- 1.4.3 Creams
- 1.4.4 Shampoo
- 1.4.5 Other
- 1.5 Market by End User
- 1.5.1 Global Head Lice Infestation Drug Market Size Growth Rate by End User
- 1.5.2 Children
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Head Lice Infestation Drug Market Size
- 2.1.1 Global Head Lice Infestation Drug Revenue 2014-2025
- 2.1.2 Global Head Lice Infestation Drug Sales 2014-2025
- 2.2 Head Lice Infestation Drug Growth Rate by Regions
- 2.2.1 Global Head Lice Infestation Drug Sales by Regions
- 2.2.2 Global Head Lice Infestation Drug Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Head Lice Infestation Drug Sales by Manufacturers
- 3.1.1 Head Lice Infestation Drug Sales by Manufacturers
- 3.1.2 Head Lice Infestation Drug Sales Market Share by Manufacturers
- 3.1.3 Global Head Lice Infestation Drug Market Concentration Ratio (CR5 and HHI)
- 3.2 Head Lice Infestation Drug Revenue by Manufacturers
- 3.2.1 Head Lice Infestation Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Head Lice Infestation Drug Revenue Share by Manufacturers (2014-2019)
- 3.3 Head Lice Infestation Drug Price by Manufacturers
- 3.4 Head Lice Infestation Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Head Lice Infestation Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Head Lice Infestation Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Head Lice Infestation Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Head Lice Infestation Drug Sales by Product
- 4.2 Global Head Lice Infestation Drug Revenue by Product
- 4.3 Head Lice Infestation Drug Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Head Lice Infestation Drug Breakdown Data by End User
6 North America
- 6.1 North America Head Lice Infestation Drug by Countries
- 6.1.1 North America Head Lice Infestation Drug Sales by Countries
- 6.1.2 North America Head Lice Infestation Drug Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Head Lice Infestation Drug by Product
- 6.3 North America Head Lice Infestation Drug by End User
7 Europe
- 7.1 Europe Head Lice Infestation Drug by Countries
- 7.1.1 Europe Head Lice Infestation Drug Sales by Countries
- 7.1.2 Europe Head Lice Infestation Drug Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Head Lice Infestation Drug by Product
- 7.3 Europe Head Lice Infestation Drug by End User
8 Asia Pacific
- 8.1 Asia Pacific Head Lice Infestation Drug by Countries
- 8.1.1 Asia Pacific Head Lice Infestation Drug Sales by Countries
- 8.1.2 Asia Pacific Head Lice Infestation Drug Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Head Lice Infestation Drug by Product
- 8.3 Asia Pacific Head Lice Infestation Drug by End User
9 Central & South America
- 9.1 Central & South America Head Lice Infestation Drug by Countries
- 9.1.1 Central & South America Head Lice Infestation Drug Sales by Countries
- 9.1.2 Central & South America Head Lice Infestation Drug Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Head Lice Infestation Drug by Product
- 9.3 Central & South America Head Lice Infestation Drug by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Head Lice Infestation Drug by Countries
- 10.1.1 Middle East and Africa Head Lice Infestation Drug Sales by Countries
- 10.1.2 Middle East and Africa Head Lice Infestation Drug Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Head Lice Infestation Drug by Product
- 10.3 Middle East and Africa Head Lice Infestation Drug by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Head Lice Infestation Drug Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Omega Pharma
- 11.2.1 Omega Pharma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Omega Pharma Head Lice Infestation Drug Products Offered
- 11.2.5 Omega Pharma Recent Development
- 11.3 Thornton and Ross
- 11.3.1 Thornton and Ross Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Thornton and Ross Head Lice Infestation Drug Products Offered
- 11.3.5 Thornton and Ross Recent Development
- 11.4 Prestige Brands
- 11.4.1 Prestige Brands Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Prestige Brands Head Lice Infestation Drug Products Offered
- 11.4.5 Prestige Brands Recent Development
- 11.5 Perrigo
- 11.5.1 Perrigo Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Perrigo Head Lice Infestation Drug Products Offered
- 11.5.5 Perrigo Recent Development
- 11.6 Actavis
- 11.6.1 Actavis Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Actavis Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Actavis Head Lice Infestation Drug Products Offered
- 11.6.5 Actavis Recent Development
- 11.7 Reckitt Benckier
- 11.7.1 Reckitt Benckier Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Reckitt Benckier Head Lice Infestation Drug Products Offered
- 11.7.5 Reckitt Benckier Recent Development
- 11.8 Tyratech
- 11.8.1 Tyratech Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Tyratech Head Lice Infestation Drug Products Offered
- 11.8.5 Tyratech Recent Development
- 11.9 Shionogi
- 11.9.1 Shionogi Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Shionogi Head Lice Infestation Drug Products Offered
- 11.9.5 Shionogi Recent Development
- 11.10 TecLabs
- 11.10.1 TecLabs Company Details
- 11.10.2 Company Business Overview
- 11.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 TecLabs Head Lice Infestation Drug Products Offered
- 11.10.5 TecLabs Recent Development
- 11.11 Arborpharma
- 11.12 Major Pharmaceuticals
- 11.13 Logic Products
- 11.14 Tianren
- 11.15 ParaPRO
12 Future Forecast
- 12.1 Head Lice Infestation Drug Market Forecast by Regions
- 12.1.1 Global Head Lice Infestation Drug Sales Forecast by Regions 2019-2025
- 12.1.2 Global Head Lice Infestation Drug Revenue Forecast by Regions 2019-2025
- 12.2 Head Lice Infestation Drug Market Forecast by Product
- 12.2.1 Global Head Lice Infestation Drug Sales Forecast by Product 2019-2025
- 12.2.2 Global Head Lice Infestation Drug Revenue Forecast by Product 2019-2025
- 12.3 Head Lice Infestation Drug Market Forecast by End User
- 12.4 North America Head Lice Infestation Drug Forecast
- 12.5 Europe Head Lice Infestation Drug Forecast
- 12.6 Asia Pacific Head Lice Infestation Drug Forecast
- 12.7 Central & South America Head Lice Infestation Drug Forecast
- 12.8 Middle East and Africa Head Lice Infestation Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Head Lice Infestation Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Head Lice Infestation Drug . Industry analysis & Market Report on Head Lice Infestation Drug is a syndicated market report, published as Global Head Lice Infestation Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Head Lice Infestation Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
